Scrip Calculation Price

RNS Number : 4699A

The MedicX Fund Limited

19 February 2014

 

For immediate release

19 February 2014

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Scrip Calculation Price for March 2014 Dividend in relation to the Scrip Dividend Scheme

On 17 May 2010 the Board of MedicX Fund Limited announced an opportunity for qualifying Shareholders to receive relevant dividends in new ordinary shares instead of in cash (the "Scheme").

In relation to the dividend for the period 1 October 2013 to 31 December 2013 payable on 31 March 2014 (the "March 2014 Dividend"), the price of a new ordinary share in relation to the Scrip Dividend Scheme (the "Scrip Calculation Price") has been set at 78.70 pence. This is the average of the closing middle market quotations for the Company's ordinary shares for the five consecutive business days commencing on the ex-dividend date of 12 February 2014.

In order to be valid, Mandate forms must be received by the Company's registrars, Capita Asset Services, (or CREST instructions entered) by no later than 5.00 p.m. on  7 March 2014 (the "Mandate Delivery Deadline") in order for elections under the Scrip Dividend Scheme to be effective in relation to the March 2014 Dividend. The Company mailed, on 18 February 2014, personalised Mandate Forms to Shareholders new on the Register since 15 November 2013 and before 14 February 2014 (the "Record Date").  Other Shareholders can use their Mandate Forms issued for previous scrip dividends offered, or obtain Mandate Forms from Capita Asset Services.

Mandate Forms remain valid for all Relevant Dividends where a Scrip Dividend Alternative is offered, until cancelled. Therefore, Shareholders who have previously completed a Mandate Form but no longer wish to receive a Scrip Dividend should write to Capita Asset Managers (at the address on page 5 of the Chairman's letter) by no later than 5.00 p.m. on the Mandate Delivery Deadline for the Relevant Dividend to inform them that they wish to revoke the election and receive a cash dividend. 

Shareholders who do not wish to receive a Scrip Dividend Alternative and have not previously completed a Mandate Form need take no further action and will receive a cash dividend in respect of the March 2014 Dividend in the usual way. The payment date in respect of the March 2014 Dividend is 31 March 2014. 

Shareholders who have any questions regarding the Scrip Dividend Scheme should contact the Capita Asset Services helpline on 0871 664 0300*.

*Calls made to this number are charged at 10 pence per minute plus network charges. Lines are open 8.30 a.m. to 5.30 p.m. (London time) Monday to Friday (except Bank Holidays).

End

For further information please contact:

MedicX Group                                                                [phone]

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

Canaccord Genuity Limited                                                [phone]

Andrew Zychowski/Helen Goldsmith

Buchanan Communications                                             [phone]

Charles Ryland/Sophie McNulty

MedicX Fund Limited                                                      [phone]

David Staples, Chairman

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 124 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 27 people operating across the UK.  

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

END

 

 

MSCQKCDBQBKDQBD